LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL
SIREN : 422174607
Employees: 02 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 1999-04-01 (27 years)Status: ActiveBusiness sector: Fabrication de parfums et de produits pour la toiletteLocation: LE SOLER (66270), Pyrenees-Orientales
LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL : revenue, balance sheet and financial ratios
LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL is a French company
founded 27 years ago,
specialized in the sector Fabrication de parfums et de produits pour la toilette.
Based in LE SOLER (66270),
this company of category PME
shows in 2019 a revenue of 856 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL (SIREN 422174607)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
856 001 €
N/C
884 678 €
889 482 €
Net income
211 380 €
237 196 €
158 196 €
207 904 €
81 501 €
38 838 €
100 422 €
132 769 €
167 412 €
EBITDA
N/C
N/C
N/C
N/C
N/C
115 035 €
N/C
191 746 €
246 860 €
Net margin
N/C
N/C
N/C
N/C
N/C
4.5%
N/C
15.0%
18.8%
Revenue and income statement
In 2024, LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL generates positive net income of 211 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 167 k€ -> 211 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
211 380 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 16%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
16.106%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
77.09%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
9.174
5.363
11.742
11.302
5.578
3.55
1.167
0.04
16.106
Financial autonomy
80.277
83.698
79.088
79.134
85.278
84.064
90.088
93.599
77.09
Repayment capacity
0.51
0.287
None
1.07
None
None
None
None
None
Cash flow / Revenue
20.419%
19.861%
None%
11.827%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
16.112024
2022
2023
2024
Q1: 0.02
Med: 16.22
Q3: 72.0
Good+23 pts over 3 years
In 2024, the debt ratio of LABORATOIRE DR REINER JAN... (16.11) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
77.09%2024
2022
2023
2024
Q1: 13.03%
Med: 38.97%
Q3: 62.54%
Excellent
In 2024, the financial autonomy of LABORATOIRE DR REINER JAN... (77.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 490.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
490.157
Liquidity indicators evolution LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
551.148
569.28
531.809
565.506
730.283
584.324
722.106
1113.479
490.157
Interest coverage
0.961
0.69
None
0.685
None
None
None
None
None
Sector positioning
Liquidity ratio
490.162024
2022
2023
2024
Q1: 133.67
Med: 232.72
Q3: 398.8
Excellent
In 2024, the liquidity ratio of LABORATOIRE DR REINER JAN... (490.16) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 204 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 559 days. Excellent situation: suppliers finance 355 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
204 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
559 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
181 170 €
342 344 €
0 €
304 676 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
62
97
0
86
0
0
0
0
0
Customer payment term (days)
13
48
353
25
0
147
233
190
204
Supplier payment term (days)
38
22
204
40
0
136
264
223
559
Positioning of LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL in its sector
Comparison with sector Fabrication de parfums et de produits pour la toilette
Valuation estimate
Based on 74 transactions of similar company sales
(all years),
the value of LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL is estimated at
113 707 €
(range 51 175€ - 895 534€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2024
74 tx
51k€113k€895k€
113 707 €Range: 51 175€ - 895 534€
Section all-time
Aggregated at NAF section level
Valuation method used
Net Income Multiple
211 380 €
×
0.5x
=113 708 €
Range: 51 175€ - 895 535€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 74 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Fabrication de parfums et de produits pour la toilette)
Compare LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL with other companies in the same sector:
Frequently asked questions about LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL
What is the revenue of LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL ?
The revenue of LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL in 2019 is 856 k€.
Is LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL profitable?
Yes, LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL generated a net profit of 211 k€ in 2024.
Where is the headquarters of LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL ?
The headquarters of LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL is located in LE SOLER (66270), in the department Pyrenees-Orientales.
Where to find the tax return of LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL ?
The tax return of LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL operate?
LABORATOIRE DR REINER JANKA BIOCOSMETIC INTERNATIONAL operates in the sector Fabrication de parfums et de produits pour la toilette (NAF code 20.42Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart